Understanding the potently immunosuppressive tumor microenvironment (TME) is critically important to deciphering the underlying mechanisms responsible for immunotherapy failure; this understanding may also help address other challenges facing immunotherapy’s full adoption, such as patient-to-patient variability and undesirable side effects. As such, a biomarker for in-depth profiling of anti-tumor immune responses is urgently needed.
Download this eBook from IsoPlexis to learn about:
- Addressing challenges in solid tumors with the Polyfunctional Strength Index (PSITM)
- Using PSI to assess T-cell function in response to small molecules
- How PSI contributes to accelerating immunotherapy discovery and development
- Employing PSI to discover novel agonist and cell therapy combinations against solid tumors